AAAAAA

   
Results: 1-10 |
Results: 10
ANGIOTENSIN-II RECEPTOR ANTAGONISM DOES NOT PREVENT TOLERANCE TO CONTINUOUS TRANSDERMAL NITROGLYCERIN
Authors: MILONE SD AZEVEDO ER PARKER AB FORSTER C PARKER JD
Citation: Sd. Milone et al., ANGIOTENSIN-II RECEPTOR ANTAGONISM DOES NOT PREVENT TOLERANCE TO CONTINUOUS TRANSDERMAL NITROGLYCERIN, Journal of the American College of Cardiology, 31(2), 1998, pp. 15-15
TRANSDERMAL NITROGLYCERIN THERAPY IS NOT ASSOCIATED WITH BIOCHEMICAL MARKERS OF OXIDATIVE STRESS
Authors: MILONE SD PACEASCIAK CR AZEVEDO ER NEWTON GE PARKER JD
Citation: Sd. Milone et al., TRANSDERMAL NITROGLYCERIN THERAPY IS NOT ASSOCIATED WITH BIOCHEMICAL MARKERS OF OXIDATIVE STRESS, Journal of the American College of Cardiology, 31(2), 1998, pp. 395-395
TRANSDERMAL NITROGLYCERIN THERAPY IS NOT ASSOCIATED WITH BIOCHEMICAL MARKERS OF FREE-RADICAL INJURY
Authors: MILONE SD PACEASCIAK CR AZEVEDO ER NEWTON GE PARKER JD
Citation: Sd. Milone et al., TRANSDERMAL NITROGLYCERIN THERAPY IS NOT ASSOCIATED WITH BIOCHEMICAL MARKERS OF FREE-RADICAL INJURY, Journal of hypertension, 16, 1998, pp. 1253-1253
ANGIOTENSIN-II RECEPTOR ANTAGONISM DOES NOT PREVENT TOLERANCE TO CONTINUOUS TRANSDERMAL NITROGLYCERIN
Authors: MILONE SD AZEVEDO ER PARKER AB FORSTER C PARKER JD
Citation: Sd. Milone et al., ANGIOTENSIN-II RECEPTOR ANTAGONISM DOES NOT PREVENT TOLERANCE TO CONTINUOUS TRANSDERMAL NITROGLYCERIN, Journal of hypertension, 16, 1998, pp. 31002-31002
ALTERATIONS IN PERIPHERAL-BLOOD LYMPHOID SUBSETS, IMMUNOGLOBULIN LEVELS AND AUTOANTIBODIES IN MULTIPLY-TRANSFUSED PATIENTS WITH BETA-THALASSEMIA
Authors: SHER GD MILONE SD TYLER B CHAN A DAVIDSON J CARSTAIRS KC
Citation: Gd. Sher et al., ALTERATIONS IN PERIPHERAL-BLOOD LYMPHOID SUBSETS, IMMUNOGLOBULIN LEVELS AND AUTOANTIBODIES IN MULTIPLY-TRANSFUSED PATIENTS WITH BETA-THALASSEMIA, Blood, 86(10), 1995, pp. 2606-2606
EVIDENCE OF REDUCTION IN HEPATIC, CARDIAC AND PITUITARY IRON STORES IN PATIENTS WITH THALASSEMIA MAJOR DURING LONG-TERM THERAPY WITH THE ORALLY-ACTIVE IRON-CHELATING AGENT L1
Authors: OLIVIERI NF BELLUZZO N MURACA M MACKENZIE CC MILONE SD POLSINELLI K KOREN G LIU PP BRITTENHAM GM
Citation: Nf. Olivieri et al., EVIDENCE OF REDUCTION IN HEPATIC, CARDIAC AND PITUITARY IRON STORES IN PATIENTS WITH THALASSEMIA MAJOR DURING LONG-TERM THERAPY WITH THE ORALLY-ACTIVE IRON-CHELATING AGENT L1, Blood, 84(10), 1994, pp. 10000109-10000109
SUCCESS, AND FAILURE, OF IRON CHELATION-THERAPY WITH THE ORALLY-ACTIVE IRON CHELATOR L1 IN 2 SISTERS
Authors: MACKINNON JA MILONE SD BRITTENHAM GM JACOB RA KUTNINK MA KOREN G OLIVIERI NF
Citation: Ja. Mackinnon et al., SUCCESS, AND FAILURE, OF IRON CHELATION-THERAPY WITH THE ORALLY-ACTIVE IRON CHELATOR L1 IN 2 SISTERS, Blood, 84(10), 1994, pp. 10000258-10000258
THE ACCURATE QUANTITATION OF TOTAL-BODY IRON BURDEN
Authors: SHER GD BELUZZO N MILONE SD PAPADOURIS D MURACA M MACKENZIE CC LIU P TEMPLETON DM BRITTENHAM GM OLIVIERI NF
Citation: Gd. Sher et al., THE ACCURATE QUANTITATION OF TOTAL-BODY IRON BURDEN, Blood, 84(10), 1994, pp. 10000363-10000363
HEPATITIS-C VIRUS (HCV) INFECTION IN TRANSFUSED PATIENTS (PTS) WITH BETA-HEMOGLOBINOPATHIES ACCELERATES IRON-INDUCED HEPATIC DAMAGE
Authors: SHER GD MILONE SD CAMERON R JAMIESON FB KRAJDEN M COLLINS AF MATSUI D ENTSUAH B BERKOVITCH M HACKMAN R FRANCOMBE WH OLIVIERI NF
Citation: Gd. Sher et al., HEPATITIS-C VIRUS (HCV) INFECTION IN TRANSFUSED PATIENTS (PTS) WITH BETA-HEMOGLOBINOPATHIES ACCELERATES IRON-INDUCED HEPATIC DAMAGE, Blood, 82(10), 1993, pp. 10000360-10000360
THE IMAGING OF CARDIAC IRON IN TRANSFUSION DEPENDENT DISEASES PATIENTS - STILL AN UNCERTAIN SCIENCE
Authors: HACKMAN R SHER GD MILONE SD LIU PP BERKOVITCH M PAPADOURIS D COLLINS AF OLIVIERI NF
Citation: R. Hackman et al., THE IMAGING OF CARDIAC IRON IN TRANSFUSION DEPENDENT DISEASES PATIENTS - STILL AN UNCERTAIN SCIENCE, Blood, 82(10), 1993, pp. 10000470-10000470
Risultati: 1-10 |